nodes	percent_of_prediction	percent_of_DWPC	metapath
Atracurium—Generalised erythema—Estradiol—osteoporosis	0.0719	0.0719	CcSEcCtD
Atracurium—Uremia—Ibandronate—osteoporosis	0.043	0.043	CcSEcCtD
Atracurium—Uremia—Pamidronate—osteoporosis	0.0337	0.0337	CcSEcCtD
Atracurium—Azotaemia—Ergocalciferol—osteoporosis	0.0331	0.0331	CcSEcCtD
Atracurium—Trauma—Ibandronate—osteoporosis	0.0228	0.0228	CcSEcCtD
Atracurium—Azotaemia—Ibandronate—osteoporosis	0.0204	0.0204	CcSEcCtD
Atracurium—Trauma—Pamidronate—osteoporosis	0.0179	0.0179	CcSEcCtD
Atracurium—Azotaemia—Pamidronate—osteoporosis	0.016	0.016	CcSEcCtD
Atracurium—Azotaemia—Zoledronate—osteoporosis	0.0146	0.0146	CcSEcCtD
Atracurium—Cardiac arrest—Calcium Acetate—osteoporosis	0.0138	0.0138	CcSEcCtD
Atracurium—Cardiovascular disorder—Estropipate—osteoporosis	0.0129	0.0129	CcSEcCtD
Atracurium—Cardiovascular disorder—Ibandronate—osteoporosis	0.0124	0.0124	CcSEcCtD
Atracurium—Bradycardia—Calcium Acetate—osteoporosis	0.0102	0.0102	CcSEcCtD
Atracurium—Cardiovascular disorder—Risedronate—osteoporosis	0.0102	0.0102	CcSEcCtD
Atracurium—Injury—Estropipate—osteoporosis	0.00895	0.00895	CcSEcCtD
Atracurium—Injury—Ibandronate—osteoporosis	0.00858	0.00858	CcSEcCtD
Atracurium—Cardiovascular disorder—Conjugated Estrogens—osteoporosis	0.00852	0.00852	CcSEcCtD
Atracurium—Anaphylactoid reaction—Estropipate—osteoporosis	0.0085	0.0085	CcSEcCtD
Atracurium—Injury—Risedronate—osteoporosis	0.00707	0.00707	CcSEcCtD
Atracurium—Cardiovascular disorder—Estradiol—osteoporosis	0.00682	0.00682	CcSEcCtD
Atracurium—Injury—Pamidronate—osteoporosis	0.00672	0.00672	CcSEcCtD
Atracurium—Bronchospasm—Ibandronate—osteoporosis	0.00671	0.00671	CcSEcCtD
Atracurium—Hypertension—Ergocalciferol—osteoporosis	0.00665	0.00665	CcSEcCtD
Atracurium—Hypotension—Calcium Acetate—osteoporosis	0.00665	0.00665	CcSEcCtD
Atracurium—Anaphylactoid reaction—Pamidronate—osteoporosis	0.00638	0.00638	CcSEcCtD
Atracurium—Injury—Conjugated Estrogens—osteoporosis	0.00591	0.00591	CcSEcCtD
Atracurium—Muscular weakness—Risedronate—osteoporosis	0.00573	0.00573	CcSEcCtD
Atracurium—Erythema—Etidronic acid—osteoporosis	0.00573	0.00573	CcSEcCtD
Atracurium—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.00562	0.00562	CcSEcCtD
Atracurium—Connective tissue disorder—Raloxifene—osteoporosis	0.00542	0.00542	CcSEcCtD
Atracurium—Connective tissue disorder—Ibandronate—osteoporosis	0.00536	0.00536	CcSEcCtD
Atracurium—Bronchospasm—Pamidronate—osteoporosis	0.00525	0.00525	CcSEcCtD
Atracurium—Hypersensitivity—Calcium Acetate—osteoporosis	0.00524	0.00524	CcSEcCtD
Atracurium—Angioedema—Etidronic acid—osteoporosis	0.00523	0.00523	CcSEcCtD
Atracurium—Angiopathy—Estropipate—osteoporosis	0.00516	0.00516	CcSEcCtD
Atracurium—Immune system disorder—Estropipate—osteoporosis	0.00514	0.00514	CcSEcCtD
Atracurium—Mediastinal disorder—Estropipate—osteoporosis	0.00513	0.00513	CcSEcCtD
Atracurium—Flushing—Raloxifene—osteoporosis	0.00512	0.00512	CcSEcCtD
Atracurium—Pruritus—Calcium Acetate—osteoporosis	0.00504	0.00504	CcSEcCtD
Atracurium—Angiopathy—Raloxifene—osteoporosis	0.005	0.005	CcSEcCtD
Atracurium—Muscular weakness—Zoledronate—osteoporosis	0.00498	0.00498	CcSEcCtD
Atracurium—Erythema—Estropipate—osteoporosis	0.00495	0.00495	CcSEcCtD
Atracurium—Angiopathy—Ibandronate—osteoporosis	0.00495	0.00495	CcSEcCtD
Atracurium—Immune system disorder—Ibandronate—osteoporosis	0.00493	0.00493	CcSEcCtD
Atracurium—Mediastinal disorder—Ibandronate—osteoporosis	0.00492	0.00492	CcSEcCtD
Atracurium—Erythema—Alendronate—osteoporosis	0.00488	0.00488	CcSEcCtD
Atracurium—Bronchospasm—Zoledronate—osteoporosis	0.0048	0.0048	CcSEcCtD
Atracurium—Erythema—Ibandronate—osteoporosis	0.00475	0.00475	CcSEcCtD
Atracurium—Injury—Estradiol—osteoporosis	0.00473	0.00473	CcSEcCtD
Atracurium—Erythema—Calcitriol—osteoporosis	0.00465	0.00465	CcSEcCtD
Atracurium—Bronchospasm—Conjugated Estrogens—osteoporosis	0.00462	0.00462	CcSEcCtD
Atracurium—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.00453	0.00453	CcSEcCtD
Atracurium—Angioedema—Estropipate—osteoporosis	0.00453	0.00453	CcSEcCtD
Atracurium—Anaphylactoid reaction—Estradiol—osteoporosis	0.00449	0.00449	CcSEcCtD
Atracurium—Angioedema—Alendronate—osteoporosis	0.00446	0.00446	CcSEcCtD
Atracurium—Connective tissue disorder—Risedronate—osteoporosis	0.00442	0.00442	CcSEcCtD
Atracurium—Angioedema—Ibandronate—osteoporosis	0.00434	0.00434	CcSEcCtD
Atracurium—Connective tissue disorder—Pamidronate—osteoporosis	0.0042	0.0042	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00419	0.00419	CcSEcCtD
Atracurium—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00418	0.00418	CcSEcCtD
Atracurium—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00417	0.00417	CcSEcCtD
Atracurium—Hypertension—Ibandronate—osteoporosis	0.0041	0.0041	CcSEcCtD
Atracurium—Angiopathy—Risedronate—osteoporosis	0.00408	0.00408	CcSEcCtD
Atracurium—Immune system disorder—Risedronate—osteoporosis	0.00406	0.00406	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00406	0.00406	CcSEcCtD
Atracurium—Mediastinal disorder—Risedronate—osteoporosis	0.00405	0.00405	CcSEcCtD
Atracurium—Anaphylactic shock—Estropipate—osteoporosis	0.00404	0.00404	CcSEcCtD
Atracurium—Convulsion—Calcitriol—osteoporosis	0.00403	0.00403	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00402	0.00402	CcSEcCtD
Atracurium—Hypertension—Calcitriol—osteoporosis	0.00401	0.00401	CcSEcCtD
Atracurium—Bradycardia—Zoledronate—osteoporosis	0.00397	0.00397	CcSEcCtD
Atracurium—Flushing—Pamidronate—osteoporosis	0.00397	0.00397	CcSEcCtD
Atracurium—Nervous system disorder—Estropipate—osteoporosis	0.00396	0.00396	CcSEcCtD
Atracurium—Skin disorder—Estropipate—osteoporosis	0.00393	0.00393	CcSEcCtD
Atracurium—Angiopathy—Pamidronate—osteoporosis	0.00388	0.00388	CcSEcCtD
Atracurium—Anaphylactic shock—Ibandronate—osteoporosis	0.00388	0.00388	CcSEcCtD
Atracurium—Immune system disorder—Pamidronate—osteoporosis	0.00386	0.00386	CcSEcCtD
Atracurium—Mediastinal disorder—Pamidronate—osteoporosis	0.00385	0.00385	CcSEcCtD
Atracurium—Nervous system disorder—Raloxifene—osteoporosis	0.00384	0.00384	CcSEcCtD
Atracurium—Connective tissue disorder—Zoledronate—osteoporosis	0.00384	0.00384	CcSEcCtD
Atracurium—Skin disorder—Raloxifene—osteoporosis	0.0038	0.0038	CcSEcCtD
Atracurium—Nervous system disorder—Ibandronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Atracurium—Anaphylactic shock—Calcitriol—osteoporosis	0.00379	0.00379	CcSEcCtD
Atracurium—Skin disorder—Ibandronate—osteoporosis	0.00377	0.00377	CcSEcCtD
Atracurium—Erythema—Pamidronate—osteoporosis	0.00372	0.00372	CcSEcCtD
Atracurium—Urticaria—Etidronic acid—osteoporosis	0.00371	0.00371	CcSEcCtD
Atracurium—Bronchospasm—Estradiol—osteoporosis	0.0037	0.0037	CcSEcCtD
Atracurium—Skin disorder—Calcitriol—osteoporosis	0.00369	0.00369	CcSEcCtD
Atracurium—Angioedema—Ethinyl Estradiol—osteoporosis	0.00367	0.00367	CcSEcCtD
Atracurium—Flushing—Zoledronate—osteoporosis	0.00362	0.00362	CcSEcCtD
Atracurium—Angioedema—Risedronate—osteoporosis	0.00358	0.00358	CcSEcCtD
Atracurium—Angiopathy—Zoledronate—osteoporosis	0.00354	0.00354	CcSEcCtD
Atracurium—Immune system disorder—Zoledronate—osteoporosis	0.00353	0.00353	CcSEcCtD
Atracurium—Mediastinal disorder—Zoledronate—osteoporosis	0.00352	0.00352	CcSEcCtD
Atracurium—Hypersensitivity—Etidronic acid—osteoporosis	0.00344	0.00344	CcSEcCtD
Atracurium—Angiopathy—Conjugated Estrogens—osteoporosis	0.00341	0.00341	CcSEcCtD
Atracurium—Angioedema—Pamidronate—osteoporosis	0.0034	0.0034	CcSEcCtD
Atracurium—Erythema—Zoledronate—osteoporosis	0.0034	0.0034	CcSEcCtD
Atracurium—Immune system disorder—Conjugated Estrogens—osteoporosis	0.0034	0.0034	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00339	0.00339	CcSEcCtD
Atracurium—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00339	0.00339	CcSEcCtD
Atracurium—Hypertension—Risedronate—osteoporosis	0.00338	0.00338	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00331	0.00331	CcSEcCtD
Atracurium—Pruritus—Etidronic acid—osteoporosis	0.00331	0.00331	CcSEcCtD
Atracurium—Erythema—Conjugated Estrogens—osteoporosis	0.00327	0.00327	CcSEcCtD
Atracurium—Convulsion—Pamidronate—osteoporosis	0.00322	0.00322	CcSEcCtD
Atracurium—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00321	0.00321	CcSEcCtD
Atracurium—Hypertension—Pamidronate—osteoporosis	0.00321	0.00321	CcSEcCtD
Atracurium—Urticaria—Estropipate—osteoporosis	0.00321	0.00321	CcSEcCtD
Atracurium—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00318	0.00318	CcSEcCtD
Atracurium—Urticaria—Alendronate—osteoporosis	0.00316	0.00316	CcSEcCtD
Atracurium—Nervous system disorder—Risedronate—osteoporosis	0.00313	0.00313	CcSEcCtD
Atracurium—Angioedema—Zoledronate—osteoporosis	0.00311	0.00311	CcSEcCtD
Atracurium—Skin disorder—Risedronate—osteoporosis	0.0031	0.0031	CcSEcCtD
Atracurium—Urticaria—Ibandronate—osteoporosis	0.00308	0.00308	CcSEcCtD
Atracurium—Anaphylactic shock—Pamidronate—osteoporosis	0.00304	0.00304	CcSEcCtD
Atracurium—Urticaria—Calcitriol—osteoporosis	0.00301	0.00301	CcSEcCtD
Atracurium—Angioedema—Conjugated Estrogens—osteoporosis	0.00299	0.00299	CcSEcCtD
Atracurium—Hypersensitivity—Estropipate—osteoporosis	0.00298	0.00298	CcSEcCtD
Atracurium—Nervous system disorder—Pamidronate—osteoporosis	0.00298	0.00298	CcSEcCtD
Atracurium—Tachycardia—Pamidronate—osteoporosis	0.00296	0.00296	CcSEcCtD
Atracurium—Connective tissue disorder—Estradiol—osteoporosis	0.00296	0.00296	CcSEcCtD
Atracurium—Rash—Etidronic acid—osteoporosis	0.00295	0.00295	CcSEcCtD
Atracurium—Convulsion—Zoledronate—osteoporosis	0.00294	0.00294	CcSEcCtD
Atracurium—Dermatitis—Etidronic acid—osteoporosis	0.00294	0.00294	CcSEcCtD
Atracurium—Hypertension—Zoledronate—osteoporosis	0.00293	0.00293	CcSEcCtD
Atracurium—Hypersensitivity—Alendronate—osteoporosis	0.00293	0.00293	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00287	0.00287	CcSEcCtD
Atracurium—Pruritus—Estropipate—osteoporosis	0.00286	0.00286	CcSEcCtD
Atracurium—Hypersensitivity—Ibandronate—osteoporosis	0.00286	0.00286	CcSEcCtD
Atracurium—Dyspnoea—Risedronate—osteoporosis	0.00285	0.00285	CcSEcCtD
Atracurium—Hypotension—Pamidronate—osteoporosis	0.00284	0.00284	CcSEcCtD
Atracurium—Convulsion—Conjugated Estrogens—osteoporosis	0.00284	0.00284	CcSEcCtD
Atracurium—Pruritus—Alendronate—osteoporosis	0.00282	0.00282	CcSEcCtD
Atracurium—Hypersensitivity—Calcitriol—osteoporosis	0.0028	0.0028	CcSEcCtD
Atracurium—Flushing—Estradiol—osteoporosis	0.00279	0.00279	CcSEcCtD
Atracurium—Anaphylactic shock—Zoledronate—osteoporosis	0.00277	0.00277	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00277	0.00277	CcSEcCtD
Atracurium—Pruritus—Ibandronate—osteoporosis	0.00274	0.00274	CcSEcCtD
Atracurium—Angiopathy—Estradiol—osteoporosis	0.00273	0.00273	CcSEcCtD
Atracurium—Nervous system disorder—Zoledronate—osteoporosis	0.00272	0.00272	CcSEcCtD
Atracurium—Immune system disorder—Estradiol—osteoporosis	0.00272	0.00272	CcSEcCtD
Atracurium—Mediastinal disorder—Estradiol—osteoporosis	0.00271	0.00271	CcSEcCtD
Atracurium—Dyspnoea—Pamidronate—osteoporosis	0.00271	0.00271	CcSEcCtD
Atracurium—Tachycardia—Zoledronate—osteoporosis	0.00271	0.00271	CcSEcCtD
Atracurium—Skin disorder—Zoledronate—osteoporosis	0.00269	0.00269	CcSEcCtD
Atracurium—Pruritus—Calcitriol—osteoporosis	0.00268	0.00268	CcSEcCtD
Atracurium—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00267	0.00267	CcSEcCtD
Atracurium—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00262	0.00262	CcSEcCtD
Atracurium—Erythema—Estradiol—osteoporosis	0.00262	0.00262	CcSEcCtD
Atracurium—Tachycardia—Conjugated Estrogens—osteoporosis	0.00261	0.00261	CcSEcCtD
Atracurium—Urticaria—Ethinyl Estradiol—osteoporosis	0.0026	0.0026	CcSEcCtD
Atracurium—Skin disorder—Conjugated Estrogens—osteoporosis	0.00259	0.00259	CcSEcCtD
Atracurium—Hypotension—Zoledronate—osteoporosis	0.00259	0.00259	CcSEcCtD
Atracurium—Rash—Estropipate—osteoporosis	0.00255	0.00255	CcSEcCtD
Atracurium—Dermatitis—Estropipate—osteoporosis	0.00255	0.00255	CcSEcCtD
Atracurium—Urticaria—Risedronate—osteoporosis	0.00254	0.00254	CcSEcCtD
Atracurium—Rash—Alendronate—osteoporosis	0.00251	0.00251	CcSEcCtD
Atracurium—Dermatitis—Alendronate—osteoporosis	0.00251	0.00251	CcSEcCtD
Atracurium—Hypotension—Conjugated Estrogens—osteoporosis	0.0025	0.0025	CcSEcCtD
Atracurium—Dyspnoea—Zoledronate—osteoporosis	0.00247	0.00247	CcSEcCtD
Atracurium—Rash—Raloxifene—osteoporosis	0.00247	0.00247	CcSEcCtD
Atracurium—Dermatitis—Raloxifene—osteoporosis	0.00247	0.00247	CcSEcCtD
Atracurium—Rash—Ibandronate—osteoporosis	0.00244	0.00244	CcSEcCtD
Atracurium—Dermatitis—Ibandronate—osteoporosis	0.00244	0.00244	CcSEcCtD
Atracurium—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00241	0.00241	CcSEcCtD
Atracurium—Angioedema—Estradiol—osteoporosis	0.00239	0.00239	CcSEcCtD
Atracurium—Rash—Calcitriol—osteoporosis	0.00239	0.00239	CcSEcCtD
Atracurium—Dermatitis—Calcitriol—osteoporosis	0.00239	0.00239	CcSEcCtD
Atracurium—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00238	0.00238	CcSEcCtD
Atracurium—Hypersensitivity—Risedronate—osteoporosis	0.00235	0.00235	CcSEcCtD
Atracurium—Pruritus—Ethinyl Estradiol—osteoporosis	0.00232	0.00232	CcSEcCtD
Atracurium—Hypertension—Estradiol—osteoporosis	0.00226	0.00226	CcSEcCtD
Atracurium—Pruritus—Risedronate—osteoporosis	0.00226	0.00226	CcSEcCtD
Atracurium—Hypersensitivity—Pamidronate—osteoporosis	0.00224	0.00224	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00221	0.00221	CcSEcCtD
Atracurium—Urticaria—Zoledronate—osteoporosis	0.0022	0.0022	CcSEcCtD
Atracurium—Pruritus—Pamidronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Atracurium—Anaphylactic shock—Estradiol—osteoporosis	0.00214	0.00214	CcSEcCtD
Atracurium—Urticaria—Conjugated Estrogens—osteoporosis	0.00212	0.00212	CcSEcCtD
Atracurium—Nervous system disorder—Estradiol—osteoporosis	0.0021	0.0021	CcSEcCtD
Atracurium—Tachycardia—Estradiol—osteoporosis	0.00209	0.00209	CcSEcCtD
Atracurium—Skin disorder—Estradiol—osteoporosis	0.00208	0.00208	CcSEcCtD
Atracurium—Rash—Ethinyl Estradiol—osteoporosis	0.00207	0.00207	CcSEcCtD
Atracurium—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00206	0.00206	CcSEcCtD
Atracurium—Hypersensitivity—Zoledronate—osteoporosis	0.00204	0.00204	CcSEcCtD
Atracurium—Rash—Risedronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Atracurium—Dermatitis—Risedronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Atracurium—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00197	0.00197	CcSEcCtD
Atracurium—Pruritus—Zoledronate—osteoporosis	0.00196	0.00196	CcSEcCtD
Atracurium—Rash—Pamidronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Atracurium—Dermatitis—Pamidronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Atracurium—Dyspnoea—Estradiol—osteoporosis	0.00191	0.00191	CcSEcCtD
Atracurium—Pruritus—Conjugated Estrogens—osteoporosis	0.00189	0.00189	CcSEcCtD
Atracurium—Rash—Zoledronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Atracurium—Dermatitis—Zoledronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Atracurium—Urticaria—Estradiol—osteoporosis	0.0017	0.0017	CcSEcCtD
Atracurium—Rash—Conjugated Estrogens—osteoporosis	0.00168	0.00168	CcSEcCtD
Atracurium—Dermatitis—Conjugated Estrogens—osteoporosis	0.00168	0.00168	CcSEcCtD
Atracurium—Hypersensitivity—Estradiol—osteoporosis	0.00158	0.00158	CcSEcCtD
Atracurium—Pruritus—Estradiol—osteoporosis	0.00151	0.00151	CcSEcCtD
Atracurium—Rash—Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
Atracurium—Dermatitis—Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
